ProSavin® a gene therapy approach for the treatment of Parkinson's Disease: a Phase I Clinical Trial Update

被引:0
|
作者
Palfi, Stephane [1 ,3 ]
Watts, Collin [4 ]
Marc, Gurruchaga Jean [3 ]
Peter, Buttery [4 ]
Scott, Ralph [2 ]
Sarah, Deeley [2 ]
Helene, Lepetit [3 ]
James, Miskin [2 ]
Hiro, Iwamuro [3 ]
Sonia, Lavisse [1 ]
Aurelie, Kas [1 ]
Laure, Ramelli Anne [3 ]
Naoki, Tani [3 ]
Gilles, Fenelon [3 ]
Pierre, Brugie're [3 ]
Stuart, Naylor [2 ]
Philippe, Hantraye [1 ]
Philippe, Remy [1 ,3 ]
Roger, Barker [4 ]
Kyriacos, Mitrophanous [2 ]
机构
[1] CEA I2BM MirCen, Fontenay Aux Roses, France
[2] Oxford Biomed Ltd, Oxford, England
[3] Hop Henri Mondor, APHP, F-94010 Creteil, France
[4] Cambridge Ctr Brain Repair, Cambridge, England
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:A61 / A61
页数:1
相关论文
共 50 条
  • [41] An Update on Gene Therapy Approaches for Parkinson's Disease: Restoration of Dopaminergic Function
    Van Laar, Amber D.
    Van Laar, Victor S.
    San Sebastian, Waldy
    Merola, Aristide
    Elder, J. Bradley
    Lonser, Russell R.
    Bankiewicz, Krystof S.
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 : S173 - S182
  • [42] An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation
    Serva, Stephanie N.
    Bernstein, Jacob
    Thompson, John A.
    Kern, Drew S.
    Ojemann, Steven G.
    FRONTIERS IN SURGERY, 2022, 9
  • [43] Drug therapy for Parkinson's disease: An update
    Omar ME Abdel-Salam
    World Journal of Pharmacology, 2015, 4 (01) : 117 - 143
  • [44] Dopaminergic Therapy in Parkinson's Disease: An Update
    Cristobal, Gurutz Linazasoro
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2008, 30 : 5 - 6
  • [45] Intrastriatal gene transfer with AAV-Neurturin for Parkinson's disease: Results of a phase I trial
    Starr, Philip A.
    Verhagen, Leo
    Larson, Paul S.
    Bakay, Roy
    Taylor, Robin
    Cahn-Weiner, Deborah
    Bartus, Raymond
    Ostrem, Jill L.
    Marks, William J., Jr.
    JOURNAL OF NEUROSURGERY, 2007, 106 (04) : A741 - A741
  • [46] Ex vivo gene therapy in the treatment of Parkinson's disease
    García-Miniet, R
    Alberti-Amador, E
    Castellano-Ortega, MR
    REVISTA DE NEUROLOGIA, 2003, 36 (11) : 1073 - 1077
  • [47] Parkinson's Disease: Clinical Review and Update
    Cabreira, Veronica
    Massano, Joao
    ACTA MEDICA PORTUGUESA, 2019, 32 (10) : 661 - 670
  • [48] RETRACTED: Approach to ex vivo gene therapy in the treatment of Parkinson's disease (Retracted Article)
    Ishida, A
    Yasuzumi, F
    BRAIN & DEVELOPMENT, 2000, 22 : S143 - S147
  • [49] Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease
    Ibon Garitaonandia
    Rodolfo Gonzalez
    Trudy Christiansen-Weber
    Tatiana Abramihina
    Maxim Poustovoitov
    Alexander Noskov
    Glenn Sherman
    Andrey Semechkin
    Evan Snyder
    Russell Kern
    Scientific Reports, 6
  • [50] Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease
    Garitaonandia, Ibon
    Gonzalez, Rodolfo
    Christiansen-Weber, Trudy
    Abramihina, Tatiana
    Poustovoitov, Maxim
    Noskov, Alexander
    Sherman, Glenn
    Semechkin, Andrey
    Snyder, Evan
    Kern, Russell
    SCIENTIFIC REPORTS, 2016, 6